, OMS | Les 10 principales causes de mortalité. WHO. Disponible sur

. France, Direction de la recherche des études de l'évaluation et des statistiques, Santé publique France. L'état de santé de la population en France: rapport 2017. 3. Risque_cardio_vasculaire_rap.pdf. Disponible sur, 2003.

A. Tedgui, La plaque. Médecine Thérapeutique, janv, vol.6, issue.10, pp.810-814, 2001.

. Sfendocrino and . Disponible,

, Haute Autorité de Santé-Principales dyslipidémies : stratégies de prise en charge

A. L. Catapano, G. I. , D. Backer, G. Wiklund, O. Chapman et al., ESC/EAS Guidelines for the Management of Dyslipidaemias, Eur Heart J, vol.37, issue.39, pp.2999-3058, 2016.

. Lipoprotéines-et-métabolisme-lipidique-|-nouvelle-société-française-d'athérosclérose and . Disponible,

J. L. Beaumont, L. A. Carlson, G. R. Cooper, Z. Fejfar, D. S. Fredrickson et al., Classification of hyperlipidaemias and hyperlipoproteinaemias, Bull World Health Organ, vol.43, issue.6, pp.891-915, 1970.

J. L. De-gennes, Idiopathic hyperlipemia. Proposition of a simplified classification, Presse Med. avr, vol.79, issue.18, pp.791-796, 1971.

M. Farnier, E. Bruckert, C. Boileau, and M. Krempf, Diagnostic et traitement des hypercholestérolémies familiales (HF) chez l'adulte : recommandations de la Nouvelle société française d'athérosclérose (NSFA)

J. Ferrières, J. B. Ruidavets, B. Perret, J. Dallongeville, D. Arveiler et al., Prevalence of dyslipidaemias in a representative sample of the French population, Arch Mal Coeur Vaiss. févr, vol.98, issue.2, pp.127-159, 2005.

A. J. Vallejo-vaz, K. Seshasai, S. R. Cole, D. Hovingh, G. K. Kastelein et al.,

P. Mata, Familial hypercholesterolaemia: A global call to arms, Atherosclerosis. nov, vol.243, issue.1, pp.257-266, 2015.

P. N. Hopkins, P. P. Toth, C. M. Ballantyne, and D. J. Rader, Familial Hypercholesterolemias: Prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia, J Clin Lipidol. juin, vol.5, issue.3, pp.9-17, 2011.

S. D. De-ferranti, A. M. Rodday, M. M. Mendelson, J. B. Wong, L. K. Leslie et al., Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES), Circulation. mars, vol.133, issue.11, pp.1067-72, 2016.

Z. Shi, B. Yuan, D. Zhao, A. W. Taylor, J. Lin et al., Familial hypercholesterolemia in China: prevalence and evidence of underdetection and undertreatment in a community population, Int J Cardiol. juill, vol.174, issue.3, pp.834-840, 2014.

G. F. Watts, J. E. Shaw, J. Pang, D. J. Magliano, G. Jennings et al.,

, Prevalence and treatment of familial hypercholesterolaemia in Australian communities, Int J Cardiol. avr, vol.185, pp.69-71, 2015.

J. Ferrières, É. Bruckert, S. Béliard, J. Rabès, M. Farnier et al., Familial hypercholesterolemia: A largely underestimated cardiovascular risk, Ann Cardiol Angeiol. mai, 2017.

M. Benn, G. F. Watts, A. Tybjaerg-hansen, and B. G. Nordestgaard, Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication, J Clin Endocrinol Metab, vol.97, issue.11, pp.3956-64, 2012.

B. G. Nordestgaard, M. J. Chapman, S. E. Humphries, H. N. Ginsberg, and L. Masana,

O. S. Descamps, Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease Consensus Statement of the European Atherosclerosis Society, Eur Heart J. déc, vol.34, issue.45, pp.3478-90, 2013.

J. Pang, E. B. Poulter, D. A. Bell, T. R. Bates, V. Jefferson et al., Frequency of familial hypercholesterolemia in patients with early-onset coronary artery disease admitted to a coronary care unit, J Clin Lipidol. sept, vol.9, issue.5, pp.703-711, 2015.

P. Gill, A. Harnden, F. Karpe, and . Familial, , vol.344, 2012.

M. Christoffersen, R. Frikke-schmidt, P. Schnohr, G. B. Jensen, B. G. Nordestgaard et al., arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study, BMJ. sept, vol.343, pp.5497-5497, 2011.

G. F. Watts, D. R. Sullivan, N. Poplawski, F. Van-bockxmeer, H. Clifton et al., Familial hypercholesterolaemia: A model of care for Australasia. Atheroscler Suppl, vol.12, pp.221-63, 2011.

S. Béliard, A. Millier, V. Carreau, A. Carrié, P. Moulin et al., The very high cardiovascular risk in heterozygous familial hypercholesterolemia: Analysis of 734 French patients, J Clin Lipidol. sept, vol.10, issue.5, pp.1129-1136, 2016.

D. I. Feldman, M. J. Blaha, R. D. Santos, S. R. Jones, R. S. Blumenthal et al., Recommendations for the management of patients with familial hypercholesterolemia, Curr Atheroscler Rep. janv, vol.17, issue.1, p.473, 2015.

M. A. Austin, C. M. Hutter, R. L. Zimmern, and S. E. Humphries, Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review, Am J Epidemiol. sept, vol.160, issue.5, pp.407-427, 2004.

M. Varret, M. Abifadel, J. Rabès, and C. Boileau, Genetic heterogeneity of autosomal dominant hypercholesterolemia, Clin Genet, vol.73, issue.1, pp.1-13, 2007.

T. Marteau, V. Senior, S. E. Humphries, M. Bobrow, T. Cranston et al., Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: A randomized controlled trial, Am J Med Genet. juill, vol.128, issue.3, pp.285-93, 2004.

K. Herman, C. Van-heyningen, and D. Wile, Cascade screening for familial hypercholesterolaemia and its effectiveness in the prevention of vascular disease, Br J Diabetes Vasc Dis. juill, vol.9, issue.4, pp.171-175, 2009.

K. Haralambos, S. D. Whatley, R. Edwards, R. Gingell, D. Townsend et al., Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales, Atherosclerosis. mai, vol.240, issue.1, pp.190-196, 2015.

C. E. Jannes, R. D. Santos, . De-souza, P. R. Silva, L. Turolla et al., Familial hypercholesterolemia in Brazil: Cascade screening program, clinical and genetic aspects, Atherosclerosis. janv, vol.238, issue.1, pp.101-108, 2015.

M. A. Umans-eckenhausen, J. C. Defesche, E. J. Sijbrands, R. L. Scheerder, and J. J. Kastelein, Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands, Lancet Lond Engl. janv, vol.357, issue.9251, pp.165-173, 2001.

D. A. Bell, J. Pang, S. Burrows, T. R. Bates, F. M. Van-bockxmeer et al., Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: An Australian experience, Atherosclerosis. mars, vol.239, issue.1, pp.93-100, 2015.

D. Marks, D. Wonderling, M. Thorogood, H. Lambert, S. E. Humphries et al., Deux tiers des patients atteints d'hypercholestérolémie familiale et éligibles aux séances de LDL-aphérèse ne sont pas traités par LDL-aphérèse : données du registre français, Ann Endocrinol. sept, vol.324, issue.7349, pp.241-243, 2002.

S. Béliard, F. Bonnet, B. Bouhanick, E. Bruckert, B. Cariou et al., Consensus statement on the management of dyslipidaemias in adults, Ann Endocrinol. févr, vol.78, issue.1, pp.43-53, 2017.

S. R. Daniels, S. S. Gidding, and S. D. De-ferranti, Pediatric aspects of Familial Hypercholesterolemias: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia, J Clin Lipidol. juin, vol.5, issue.3, pp.30-37, 2011.

A. Kirke, G. F. Watts, and J. Emery, Detecting familial hypercholesterolaemia in general practice, Aust Fam Physician. déc, vol.41, issue.12, pp.965-973, 2012.

J. Rabès, S. Béliard, A. Carrié, D. A. Bell, A. J. Hooper et al., Opportunistic screening for familial hypercholesterolaemia via a community laboratory, Curr Opin Lipidol. avr, vol.29, issue.2, pp.534-541, 2012.

D. A. Bell, J. Garton-smith, A. Vickery, A. B. Kirke, J. Pang et al., Significant gaps in awareness of familial hypercholesterolemia among physicians in selected Asia-Pacific countries: A pilot study, J Clin Lipidol. janv, vol.23, issue.4, pp.42-50, 2014.

H. A. Neil, T. Hammond, R. Huxley, D. R. Matthews, and S. E. Humphries, Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study, BMJ. juill, vol.321, issue.7254, p.148, 2000.

J. Schofield, S. Kwok, M. France, N. Capps, R. Eatough et al., Knowledge gaps in the management of familial hypercholesterolaemia. A UK based survey, Atherosclerosis. sept, vol.252, pp.161-166, 2016.

B. Withycombe, J. C. Winden, R. Hassanyn, P. B. Duell, and M. K. Ito, The extent of familial hypercholesterolemia instruction in US schools and colleges of medicine, pharmacy, and osteopathic medicine, J Clin Lipidol. mai, vol.9, issue.3, pp.281-289, 2015.

M. A. Batais, T. H. Almigbal, B. Abdulhak, A. A. Altaradi, H. B. Alhabib et al.,

, Assessment of physicians' awareness and knowledge of familial hypercholesterolemia in Saudi Arabia: Is there a gap? PloS One, vol.12, p.183494, 2017.

J. Pang, M. Hu, J. Lin, T. Miida, H. M. Nawawi et al., An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the AsiaPacific region: the « Ten Countries Study, BMJ Open, vol.7, issue.10, p.17817, 2017.

P. Michot, O. Catala, I. Supper, R. Boulieu, Y. Zerbib et al., Coopération entre médecins généralistes et pharmaciens : une revue systématique de la littérature, Cooperation between general practitioners and pharmacists: a systematic review, Santé Publique. août, vol.25, issue.3, pp.331-372, 2013.

Z. Ademi, G. F. Watts, J. Pang, E. Sijbrands, F. M. Van-bockxmeer et al., Cascade screening based on genetic testing is cost-effective: Evidence for the implementation of models of care for familial hypercholesterolemia, J Clin Lipidol. juill, vol.8, issue.4, pp.390-400, 2014.

S. Kwok, J. Pang, S. Adam, G. F. Watts, and H. Soran, An online questionnaire survey of UK general practitioners' knowledge and management of familial hypercholesterolaemia, F. Pratiques et opinions des médecins généralistes en matière de prévention, vol.6, p.5, 2016.

A. L. Catapano and O. Wiklund, Think Again About Cholesterol Survey. Atheroscler Suppl. déc, vol.20, pp.1-5, 2015.

D. S. Wald, J. P. Bestwick, J. K. Morris, K. Whyte, L. Jenkins et al., Child-Parent Familial Hypercholesterolemia Screening in Primary Care, N Engl J Med, vol.375, issue.17, pp.1628-1665, 2016.

. Le-papier-n, est pas mort : c'est même le support préféré des médecins